4//SEC Filing
BENDHEIM JACK 4
Accession 0001104659-26-003467
CIK 0001069899other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 6:53 PM ET
Size
8.1 KB
Accession
0001104659-26-003467
Insider Transaction Report
Form 4
BENDHEIM JACK
DirectorPresident and CEO10% Owner
Transactions
- Sale
Class A Common Stock
[F1][F2]2026-01-09$40.16/sh−213$8,554→ 38,659 total(indirect: See)
Holdings
- 16,840
Class A Common Stock
[F3]
BFI Co., LLC
10% Owner
Transactions
- Sale
Class A Common Stock
[F1][F2]2026-01-09$40.16/sh−213$8,554→ 38,659 total(indirect: See)
Holdings
- 16,840
Class A Common Stock
[F3]
Footnotes (3)
- [F1]The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC ("BFI") on May 30, 2025.
- [F2]The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of Phibro Animal Health Corporation (the "Issuer"), exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- [F3]The reported securities are directly held by Jack Bendheim.
Documents
Issuer
PHIBRO ANIMAL HEALTH CORP
CIK 0001069899
Entity typeother
Related Parties
1- filerCIK 0001241560
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 6:53 PM ET
- Size
- 8.1 KB